These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 29380491
1. Extracorporeal photopheresis as second-line treatment therapy in life-threatening primary graft dysfunction following lung transplantation. Robinson CA, Inci I, Naegeli M, Murer C, Schuurmans MM, Urosevic-Maiwald M, Schüpbach R, Weder W, Benden C. Pediatr Transplant; 2018 May; 22(3):e13145. PubMed ID: 29380491 [Abstract] [Full Text] [Related]
2. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review. Benden C, Haughton M, Leonard S, Huber LC. J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986 [Abstract] [Full Text] [Related]
3. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction. Gautschi F, Vogelmann T, Ortmanns G, Knörr F, Steinack C, Hage R, Nägeli M, Schuurmans MM. J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041 [Abstract] [Full Text] [Related]
5. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience. Vazirani J, Routledge D, Snell GI, Watson D, Paraskeva M, Westall GP, Harrison SJ. Transplant Proc; 2021 Jun; 53(1):296-302. PubMed ID: 33039145 [Abstract] [Full Text] [Related]
6. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK). Fisher AJ, White M, Goudie N, Kershaw A, Phillipson J, Bardgett M, Lally J, Bevin-Nicholls A, Chadwick T, Bryant A, Russell S, Smith H, Frisby L, Errington R, Carby M, Thompson R, Santhanakrishnan K, Parmar J, Lordan JL, Vale L, Hancock H, Exley C, Gennery AR, Wason JM. BMJ Open Respir Res; 2024 May 09; 11(1):. PubMed ID: 38724453 [Abstract] [Full Text] [Related]
17. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. Jaksch P, Scheed A, Keplinger M, Ernst MB, Dani T, Just U, Nahavandi H, Klepetko W, Knobler R. J Heart Lung Transplant; 2012 Sep 15; 31(9):950-7. PubMed ID: 22884382 [Abstract] [Full Text] [Related]
18. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation. Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S, Aljitawi OS, Lin TL, Singh A, Abhyankar S. J Clin Apher; 2016 Aug 15; 31(4):347-52. PubMed ID: 26031713 [Abstract] [Full Text] [Related]
20. Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience. Teszak T, Assabiny A, Kiraly A, Tarjanyi Z, Parazs N, Szakal-Toth Z, Hartyanszky I, Szabolcs Z, Racz K, Reti M, Merkely B, Sax B. Transpl Immunol; 2023 Aug 15; 79():101853. PubMed ID: 37196865 [Abstract] [Full Text] [Related] Page: [Next] [New Search]